1 Result(s)

Article

Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia

CD19-specific chimeric antigen receptor T cell (CD19 CAR T) therapy has shown high remission rates in patients with refractory/relapsed B-cell acute lymphoblastic leukemia (r/r B-ALL). However, the long-term o...

Furun An, Hui** Wang, Zhenyun Liu, Fan Wu, Jiakui Zhang… in Nature Communications (2020)